VERU INC. Other Non-Current Assets
VERU INC. (VERU) had Other Non-Current Assets of $298.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Assets, Noncurrent $298.00K.
- 2026-03-31: Other Assets, Noncurrent $60.55K.
- 2025-12-31: Other Assets, Noncurrent $930.85K.
- 2025-09-30: Other Assets, Noncurrent $930.85K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $298.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $60.55K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $930.85K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $930.85K 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $989.60K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $989.60K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $989.60K 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $989.60K 10-K · filed 2025-12-17 | $1.13M 10-K · filed 2024-12-16 |
| 2024-06-30 | $1.32M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.32M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $1.51M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $1.55M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $778.70K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $856.43K 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $1.56M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $2.28M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.29M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $878.42K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $878.50K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $880.89K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $762.75K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $762.01K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $766.12K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $1.56M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.49M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $675.91K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $988.87K 10-K · filed 2020-12-10 | |
| 2019-06-30 | $684.09K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $776.18K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $773.86K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $965.15K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $527.25K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $165.96K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $159.66K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $186.43K 10-K · filed 2018-12-13 | $156.43K 10-K · filed 2018-01-02 |
| 2017-06-30 | $183.32K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $179.03K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $178.58K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $189.22K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $191.07K 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $142.34K 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $137.62K 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $136.77K 10-K · filed 2016-12-12 | |
| 2015-06-30 | $151.40K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $148.87K 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $156.96K 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $166.08K 10-K · filed 2015-12-02 | |
| 2014-06-30 | $174.57K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $157.72K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $146.96K 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $138.46K 10-K · filed 2014-12-02 | |
| 2013-06-30 | $126.80K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $127.49K 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $121.98K 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $122.34K 10-K · filed 2013-12-03 | |
| 2012-06-30 | $118.18K 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $121.96K 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $117.83K 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $116.36K 10-K · filed 2012-12-04 | |
| 2011-06-30 | $120.34K 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $178.71K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |